Improved clinical and radiographic outcomes after treatment with ivacaftor in a young adult with cystic fibrosis with the P67L CFTR mutation

Chest
Shatha YousefAndrew A Colin

Abstract

The underlying cause of cystic fibrosis (CF) is the loss of epithelial chloride and bicarbonate transport due to mutations in the CF transmembrane conductance regulator (CFTR) gene encoding the CFTR protein. Ivacaftor is a gene-specific CFTR potentiator that augments in vivo chloride transport in CFTR mutations affecting channel gating. Originally approved for the G511D CFTR mutation, ivacaftor is now approved for eight additional alleles exhibiting gating defects and has also been tested in R117H, a CFTR mutation with residual function that exhibits abnormal gating. P67L is a class 4 conductance (nongating) mutation exhibiting residual CFTR function. We report marked clinical improvement, normalization of spirometry, and dramatic reduction in radiographic structural airway changes after > 1 year of treatment with ivacaftor in a young adult with the compound heterozygous genotype P67L/F508del CFTR. The case suggests that ivacaftor may have a potential benefit for patients with CF with nongating mutations.

References

May 13, 2005·The New England Journal of Medicine·Steven M RoweEric J Sorscher
Oct 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Fredrick Van GoorPaul Negulescu
Nov 19, 2010·The New England Journal of Medicine·Frank J AccursoBonnie W Ramsey
Nov 4, 2011·The New England Journal of Medicine·Bonnie W RamseyUNKNOWN VX08-770-102 Study Group
Feb 2, 2012·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Haihui YuFredrick Van Goor
Mar 3, 2012·Chest·Patrick A FlumeUNKNOWN VX 08-770-104 Study Group
May 3, 2013·American Journal of Respiratory and Critical Care Medicine·Christopher H Goss, Felix Ratjen
Jul 31, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Fredrick Van GoorBeth J Hoffman
Feb 18, 2014·American Journal of Respiratory and Critical Care Medicine·Siobhan HoareJonathan D Dodd
Jun 14, 2014·American Journal of Respiratory and Critical Care Medicine·Steven M RoweUNKNOWN GOAL Investigators of the Cystic Fibrosis Foundation Therapeutics Development Network
Aug 8, 2014·Science Translational Medicine·Deborah M CholonMartina Gentzsch
Aug 8, 2014·Science Translational Medicine·Guido VeitGergely L Lukacs

❮ Previous
Next ❯

Citations

Feb 10, 2016·Clinics in Chest Medicine·Jerry A Nick, David P Nichols
Jun 23, 2015·Pediatric Pulmonology·George M SolomonSteven M Rowe
Nov 5, 2016·Respiratory Medicine Case Reports·S GuiguiR I Cohen
Jan 20, 2018·American Journal of Physiology. Lung Cellular and Molecular Physiology·Misak HarutyunyanAnjaparavanda P Naren
Feb 13, 2019·Human Molecular Genetics·Frédéric AnglèsWilliam E Balch
Sep 8, 2017·Pediatric Pulmonology·Jennifer GuimbellotSteven M Rowe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Verena I SeligerPeter Mueller
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Shahid I SheikhDon Hayes
The New England Journal of Medicine
Bonnie W RamseyVX08-770-102 Study Group
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Lucian FrenţescuGheorghe Benga
© 2022 Meta ULC. All rights reserved